Site icon swarb.co.uk

Viridis Pharmaceutical v EUIPO – Hecht-Pharma (Boswelan): ECFI 15 Sep 2017

Intellectual, Industrial and Commercial Property – Trade Marks : Judgment – European trade mark – Lapse proceedings – European Union word mark Boswelan – Declaration of disqualification – Article 51 (1) (a) of Regulation (EC) No 207/2009 – Absence of use seriousness of the mark – Absence of just reasons for non-use

Citations:

T-276/16, [2017] EUECJ T-276/16

Links:

Bailii

Jurisdiction:

European

Intellectual Property

Updated: 30 March 2022; Ref: scu.595421

Exit mobile version